- Home
- ARMP vs NTZ Comparison
ARMP vs NTZ Comparison
Compare ARMP & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- NTZ
- Stock Information
- Founded
- ARMP N/A
- NTZ 1959
- Country
- ARMP United States
- NTZ Italy
- Employees
- ARMP N/A
- NTZ 3205
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- NTZ Home Furnishings
- Sector
- ARMP Health Care
- NTZ Consumer Discretionary
- Exchange
- ARMP Nasdaq
- NTZ Nasdaq
- Market Cap
- ARMP 52.1M
- NTZ 39.0M
- IPO Year
- ARMP N/A
- NTZ 1993
- Fundamental
- Price
- ARMP $1.95
- NTZ $4.28
- Analyst Decision
- ARMP Strong Buy
- NTZ
- Analyst Count
- ARMP 1
- NTZ 0
- Target Price
- ARMP $9.00
- NTZ N/A
- AVG Volume (30 Days)
- ARMP 624.1K
- NTZ 6.3K
- Earning Date
- ARMP 05-14-2025
- NTZ 06-20-2025
- Dividend Yield
- ARMP N/A
- NTZ N/A
- EPS Growth
- ARMP N/A
- NTZ N/A
- EPS
- ARMP N/A
- NTZ N/A
- Revenue
- ARMP $4,699,000.00
- NTZ $330,051,765.00
- Revenue This Year
- ARMP $8.43
- NTZ N/A
- Revenue Next Year
- ARMP N/A
- NTZ N/A
- P/E Ratio
- ARMP N/A
- NTZ N/A
- Revenue Growth
- ARMP 14.24
- NTZ N/A
- 52 Week Low
- ARMP $0.90
- NTZ $3.07
- 52 Week High
- ARMP $3.42
- NTZ $6.27
- Technical
- Relative Strength Index (RSI)
- ARMP 56.79
- NTZ 61.35
- Support Level
- ARMP $1.74
- NTZ $3.07
- Resistance Level
- ARMP $2.20
- NTZ $4.32
- Average True Range (ATR)
- ARMP 0.32
- NTZ 0.19
- MACD
- ARMP 0.04
- NTZ 0.12
- Stochastic Oscillator
- ARMP 50.32
- NTZ 96.80
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.